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Abstract
Salmonella as a causative agent in septic bursitis 
is considered rare. We report a case of 56 years 
old male with history of renal transplantation and 
using mycophenolate mofetil, cyclosporine and 
methylprednisolone as maintenance, admitted due to 
3-week-fever associated with tenderness and swelling 
on left shoulder. Upon investigation, a diagnosis of septic 
bursitis was established. Salmonella enteritidis as the 
definitive causative agent was revealed. He was treated 
with meropenem 1g IV three times daily and levofloxacin 
500 mg IV once a day for 3 weeks, followed by oral 
ciprofloxacin 500 mg twice a day for 2 weeks and oral 
metronidazole 500 mg three times a day for 1 week 
with a total duration of 5 weeks of antibiotics. On the 
subsequent follow up there was no recurrence episode 
of fever and the swelling of the left shoulder subsided, 
no tenderness noted and the patient has no limitation 
of range of movement. Since immunocompromised 
state complicates the management, the duration of 
therapy may twice longer than the typical management 
of septic bursitis. Salmonella as etiologic agent should 
be considered as differential in immunocompromised 
patient with septic bursitis.
Keywords: Immunocompromised state, septic bursitis, 
deep bursae, Salmonella, duration of therapy.
Introduction
Bursae is an enclosed sac which contains a small 
amount of synovial fluid, lined with a cellular 
membrane similar to synovium.1-3,7 Bursae may be 
divided based on its location into superficial and 
deep. Septic bursitis on deep bursae may occurred 
in patients with bacteremia and more common in 
the immunocompromised state.2-8,16,20 The patient is 
in immunosuppressive therapy on mycophenolate 
mofetil and cyclosporine secondary to post renal 
transplantation.
Septic bursitis refers to inflammation of the 
bursae which is due to infection, typically resulting 
from bacterial inoculation either direct (e.g 
puncture wound), spread from nearby soft tissues 
(e.g, cellulitis), or hematogenous (e.g, bacterial 
endocarditis). Mycobacteria, fungi, or algae are 
less common as the causative agents.
The most common cause of septic bursitis both 
in immunocompetent or immunocompromised 
population mentioned in some references is 
Staphylococcus aureus (>80%) followed by 
Streptococcus.2,6,12,16 Salmonella as an etiologic 
agent in septic bursitis is rare and reported in less 
than 1% as an infectious cause in bone and joint 
infection.20 In this case report, we present a case of 
septic bursitis in immunocompromised patient with 
Salmonella enteritidis as the causative agent.
Case Report
A 56 years old male with a history of renal 
transplantation and using mycophenolate mofetil 
(2x250 mg), cyclosporine (2x25 mg), and 
methylprednisolone (2 mg, q48h) as maintenance, 
presented with a chief complaint of fever associated 
with left shoulder tenderness for 3 weeks prior 
to admission. Initially, he got recurrent fever 
for 1 week and more frequent at night. He was 
medicated himself with over the counter medicine, 
no consult to physician was done. Three weeks 
prior to admission, he began complaining of left 
shoulder stiffness and swelling. He was consult to 
a physician, upon ultrasound examination revealed 
fluid accumulation on his left shoulder. Fluid 
aspiration culture result shown Salmonella spp. 
Then, He was referred to Cipto Mangunkusumo 
General Hospital for further evaluation and 
management.
On physical examination, temperature of his 
body was 38.5 0C and other vital signs were normal. 
The patient was able to walk, but he had an obvious 
pain and fatigue. His left shoulder was swollen 
and fluctuation, limited of range of movement, no 
wound puncture or sign of skin infections either on 
the left shoulder or other parts of the body.
Upon admission, accumulation of fluid on 
subacromion subdeltoid bursa was found by 
ultrasound, fluid aspiration was yellow and cloudy 
fluid (Figure 1). Fluid analysis shown 208440 cells/
µl with 94% neutrophils (Table 1 and Table 2). A 
culture of the bursa aspirate revealed Salmonella 
enteritidis. Then the patient was given meropenem 
1g IV q8h and levofloxacin 500 mg IV once a 
day for three weeks. Mycophenolate mofetil and 
cyclosporine was continued.
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Table 1. Laboratory examination result
Parameters Result Reference
Hb 9.1 g/dL 13−16 g/dL
Ht 26.5% 40−48%
MCV 71 fL 82−92 fL
MCH 24.4 pg 27−31 pg
WBC 4.85x103 /µL 5−10 x 103 /µL
Platelets 129000 150000−400000
Diff count
Eosinophil 1.4% 1−3%
Neutrophil 48.3% 52−76%
Lymphocyte 37.9% 20−40%
Monocyte 12.2% 2−8%
Ureum 47 mg/dL <50 mg/dL
Creatinine 1.00 mg/dL 0.8−1.3 mg/dL
eGFR 83.8 mL/min/1.73 m2 79−117 mL/min/1,73 m2
Na 148 mEq/L 132−147 mEq/L
K 3.8 mEq/L 3.3−5.4 mEq/L
Procalcitonin 1.07 ng/mL <0.05 ng/mL
Hb: Hemoglobin; Ht: Hematocrite; MCV: Mean Corpuscular Volume; 
MCH: Mean Corpuscular Hemoglobin; WBC: White Blood Cells; eGFR: 
Estimated Glomerular Filtration Rate; Na: Sodium; K: Potassium
Table 2. Bursal fluid analysis
Test Reference Result
Macroscopic
Color Colorless Brown
Clarity Clear Cloudy
Viscosity <4 cm
Mucin clot test Negative Poor
Microscopic
Cell count 208440/µL
Diff. count
PMN (segment) 196680 (94%)/µL
MN (lymphocyte) 11760.0 (0.05%)/µL
Crystals No uric crystals found
Fluid Protein 8.0
Fluid Glucose 80
Fluid uric acid 6
Serum uric acid 3.5−7.2 4.0
Rheumatoid Factor <11
PMN: Polymorphonuclear cells; MN: Mononuclear cells
During hospitalization, there was no recurrence episode 
of fever and swelling on the left shoulder. MRI (Magnetic 
Resonance Imaging) on left shoulder shown abscess 
formation with M. supraspinatus, tendon of M. biceps brachii 
and left subacromial bursa involvement. After 3 weeks of 
hospitalization, ultrasound examination revealed no fluid 
accumulation in subacromial subdeltoid bursae (Figure 2). 
Antibiotics shifted to oral ciprofloxacin 500 mg twice a day 
for 2 weeks and metronidazole 500 mg thrice a day for 1 
week, hence discharged. Three weeks after discharged, there 
was no recurrence episode of fever and the swelling on the left 
shoulder subsided, no tenderness noted and the patient has no 
limitation of range of movement.
Figure 1. Ultrasound of the left shoulder, prior aspiration (left) 
and on aspiration (right)
Figure 2. MRI of the left shoulder
Figure 3. Photos taken after 3 weeks of antibiotic course.
The left shoulder swelling subsided.
Discussion
Bursitis is an inflammation or degeneration of the sac-like 
structures which form in utero to protect the soft tissues 
from underlying bony prominences.9 Septic bursitis refers to 
inflammation of the bursae which is cause infection. Septic 
bursitis on deep bursae may have been occurred in patients with 
bacteremia which is more common in the immunocompromised 
state.2-8,16,20 Direct inoculation to deep bursae (e.g,  subacromial, 
iliopsoas, trochanter bursae) is rare although iatrogenic 
infections may occur through injection procedure to the 
bursa, intra articular injection, acupuncture.16,17 If no direct 
inoculation or iatrogenic course found, hematogenous seeding 
and impaired response to infection as one of the predisposing 
factor must be considered.16 In our report, the patient is 
taking immunosuppressive agent (i.e mycophenolate mofetil, 
cyclosporine and methylprednisolone). 
The definitive pathogen in this case is Salmonella 
enteritidis inoculated from the infected bursa. Salmonella is 
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considered rare as a causative agent in both septic bursitis 
and septic arthritis.4,5,18,20 Sky et al, in his report mentioned 
the Salmonella as etiologic agent in bone and joint infection 
in <1% of cases.20 The peak incidence of nontyphoidal 
salmonella (NTS) is on rainy season in tropical climates, and 
during the warmer months in temperate climates, coinciding 
with the peak in foodborne outbreaks.18 The mortality and 
morbidity is significant in immunocompromised populations. 
Transmission is most commonly associated with animal food 
products, especially egg, poultry, undercooked ground meat, 
dairy products, and fresh produce contaminated with animal 
waste.18 More than 8% of this infection causes bacteremia.13
Diagnostic approach in septic bursitis includes history 
and physical examination. Ultrasound, CT scan, MRI, are 
tools which help in defining bursal effusion within deep 
bursae. Bursal fluid aspiration is indicated if effusions and 
septic bursitis are present or suspected. Laboratory analysis of 
bursal fluid consists determination of the nucleated cell count 
(white cell count), gram stain, and culture for bacteria.7,16 
Immunocompromised hosts may have more limited 
inflammatory response. A threshold for bursal leukocytosis of 
>2000/mm3 [>2.0 x 109/L] was noted to have a sensitivity and 
specificity for septic bursitis of 94 % and 79 %, respectively, 
in a study of 36 patients with olecranon or prepatellar bursitis. 
The sensitivity of gram stain ranges from 15 − 100 %. Bursal 
fluid glucose utility is uncertain, the majority of patients with 
septic bursitis have a low glucose level defined as serum 
glucose ratio <50%.16
Overall, management of septic bursitis includes 
antibiotic therapy, drainage, and surgical intervention.14 In 
our case, we administered antibiotic therapy and drainage. 
The differentiation of management in immunocompetent 
and immunocompromised host is the duration of antibiotic 
therapy. The immunosuppressive agents taken by the patient 
complicates the treatment. Duration of antibiotic therapy 
in septic bursitis is determined by the clinical response, 
microbiologic findings, and patient’s general conditions. In 
general, antibiotic therapy is given in 2−3 weeks duration 
and more prolonged between 4 and 6 weeks in more 
serious infection in compromised host or even three times 
longer.2,14-16,19 Hirsansuthikul et al, 2016 reported antibiotic 
duration for 5 weeks in management of septic bursitis  in HIV 
patients.3 Olut et al, 2012 in his case report giving antibiotics 
for 8 weeks in managing septic arthritis of hip caused S.Typhi 
in a multiple sclerosis patient who was under steroid therapy.5 
Both of the reports give an excellent follow up with no 
significant residual lesion.3,5 In our report, we administered 
meropenem 3x1g IV, levofloxacin 1x500 mg IV as guided by 
the culture results for 3 weeks, followed by oral ciprofloxacin 
2x500 mg for 2 weeks and oral metronidazol 3x500 mg for 1 
week with a total duration of 5 weeks. On subsequent follow 
up, the patient reported no recurrence of fever, improvement 
on the left shoulder tenderness and range of movement, the 
swelling is subsided.
Conclusion
Septic bursitis is referred as a condition of infection in 
bursa which may occur from direct inoculation, iatrogenic 
cause from joint aspiration, or hematogenic seeding from 
bacteremia. Septic bursitis on deep bursae may have been 
occurred in patients with bacteremia which is more common 
in the immunocompromised state. Salmonella is considered 
rare as a causative agent in both septic bursitis and septic 
arthritis, more than 8% of this infection causes bacteremia. 
Bursal fluid analysis and culture may confirm the diagnosis. 
Immunocompromised state complicates the management of 
septic bursitis, hence the duration of therapy may twice longer 
than the typical duration in the immunocompetent host.
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